Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

EpimAb Out-licenses Use of its Bispecific Platform to Almirall in $210 Million Agreement

publication date: Oct 16, 2023

Shanghai EpimAb Biotherapeutics out-licensed the rights for its proprietary Fabs-In-Tandem Immunoglobulin (FIT-Ig®) platform technology to Barcelona’s Almirall, a dermatology company. Almirall will have global ownership of up to three bispecific antibodies it discovers and develops using the platform. EpimAb will receive as much as $210 million in milestones contingent upon launch and commercial success of the products, plus royalties. FIT-Ig® generates bispecific antibodies using only the basic structural parts of monoclonal antibodies. EpimAb has developed seven clinical-stage bispecific molecules from the platform. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital